The biotechnology sector, encompassing areas from pharmaceuticals to agriculture, has seen considerable expansion owing to significant strides in drug development, heightened merger and acquisition activities, and technology advancements.
Therefore, investors could consider adding fundamentally strong biotech stocks BioNTech SE (BNTX), Entrada Therapeutics, Inc. (TRDA), and Incyte Corporation (INCY) to the portfolio this week.
